top of page

CorNeat EverPatch Hits the US Market: Farewell to Traditional Ocular Tissue Grafts

Feb 2024

Farewell to Traditional Ocular Tissue Grafts!

CorNeat Vision, a leader in innovative medical device solutions, proudly introduces the CorNeat EverPatch, a pioneering synthetic tissue substitute, designed to revolutionize ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device represents a significant leap forward in addressing complications related to surgical interventions of the ocular surface.

Read all about it here

bottom of page